Biomedical imaging in the safety evaluation of new drugs

Laboratory Animals

Volumn 42, Issue 4, 2008, Pages 433-441

  Wang, Yi Xiang J ^a   Yan, Sen Xiang ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Biomarker; Drug discovery; Drug safety; Imaging; Toxicology

Indexed keywords

ANESTHETIC AGENT; BIOLOGICAL MARKER; EFENAMIC ACID; GADOLINIUM CHELATE; IODINATED CONTRAST MEDIUM; TIOGUANINE; VIGABATRIN;

CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG SAFETY; ECHOGRAPHY; ENTERITIS; HUMAN; IMAGING SYSTEM; LIVER TOXICITY; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NODULAR HYPERPLASIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TOXICITY TESTING; X RAY ANALYSIS;

ANIMALS; DIAGNOSTIC IMAGING; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TOXICITY TESTS; ULTRASONOGRAPHY;

ANIMALIA;

EID: 55049116679     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2007.007022     Document Type: Review

References (38)

1. Bach PH, Nguyen TK (1998) Renal papillary necrosis - 40 years on. Toxicologic Pathology 26, 73-91
2. Beckmann N, Laurent D, Tigani B, Panizzutti R, Rudin M (2004) Magnetic resonance imaging in drug discovery: lessons from disease areas. Drug Discovery Today 9, 35-42
3. Bianchi G, Albanell J, Eiermann W, et al. (2003) Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer. Clinical Cancer Research 9, 5944-51
4. Brix AE (2002) Renal papillary necrosis. Toxicologic Pathology 30, 672-4
5. Butler WH (1989) The neuropathology of vigabatrin. Epilepsia 30(suppl. 3), S15-17
6. Butler WH, Ford GP, Newberne JW (1987) A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicologic Pathology 15, 143-8
7. Cohen JA, Fisher RS, Brigell MG, Peyster RG, Sze G (2000) The potential for vigabatrin-induced intramyelinic edema in humans. Epilepsia 41, 148-57
8. Delnomdedieu M, Hedlund LW, Johnson GA, Maronpot RR (1996) Magnetic resonance microscopy - a new tool for the toxicologic pathologist. Toxicologic Pathology 24, 36-44
9. Diehl AM (1999) Nonalcoholic steatohepatitis. Seminars in Liver Disease 19, 221-9
10. Faber C, Schweitzer W, Bar W, Haase A (2003) Magnetic resonance microscopy of the human cardiac conduction system at 17.6 Tesla. In: Proceedings of International Society for Magnetic Resonance in Medicine. Toronto: No. 807
11. Hanai K, Takaba K, Manabe S, Nakano M, Kohda A, Matsuo M (1996) Evaluation of cardiac function by echocardiography in dogs treated with doxorubicin. Journal of Toxicological Sciences 21, 1-10
12. Heiken JP, Lee JK, Dixon WT (1985) Fatty infiltration of the liver: evaluation by proton spectroscopic imaging. Radiology 157, 707-10
13. Hockings PD, Changani KK, Saeed N, et al. (2003) Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes, Obesity and Metabolism 5, 234-43
14. Jackson GD, Williams SR, Weller RO, et al. (1994) Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging. Epilepsy Research 18, 57-66
15. Johnson K, Ryan L, Davis J, et al. (2006) Application of magnetic resonance imaging in developmental neurotoxicity testing: a pilot study. Neurotoxicology 27, 846-51
16. Kellie SJ, Chaku J, Lockwood LR, O'Regan P, Waters KD, Wong CK (2005) Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. European Journal of Cancer 41, 1588-96
17. Lang EK, Thomas R, Davis R, et al. (2004) Multiphasic helical CT diagnosis of early medullary and papillary necrosis. Journal of Endourology 18, 167-71
18. Lester DS, Lyon R, McGregor GN, et al. (1999) 3-dimensional visualization of lesions in rat brain using magnetic resonance imaging microscopy. NeuroReport 10, 737-41
19. Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. Journal of Magnetic Resonance Imaging 5, 281-5
20. Maronpot RR, Sills RC, Johnson GA (2004) Applications of magnetic resonance microscopy. Toxicologic Pathology 32, 42-8
21. Mimbs JW, O'Donnell M, Miller JG, Sobel BE (1981) Detection of cardiomyopathic changes induced by doxorubicin based on quantitative analysis of ultrasonic backscatter. American Journal of Cardiology 47, 1056-60
22. Peyster RG, Sussman NM, Hershey BL, et al. (1995) Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain. Epilepsia 36, 93-100
23. Pogge A, Slikker W Jr (2004) Neuroimaging: new approaches for neurotoxicology. Neurotoxicology 25, 525-31
24. Seiderer J, Zech CJ, Reinisch W, et al. (2005) A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. Journal of Hepatology 43, 303-9
25. Sills RC, Morgan DL, Herr DW, et al. (2004) Contribution of magnetic resonance microscopy in the 12-week neurotoxicity evaluation of carbonyl sulfide in Fischer 344 rats. Toxicologic Pathology 32, 501-10
26. Szczepaniak LS, Babcock EE, Schick F, et al. (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. American Journal of Physiology 276, E977-89
27. Thompson K, Wisenberg G, Sykes J, Thompson RT (2003) MRI/MRS evaluation of cariporide in a canine long-term model of reperfused ischemic insults. Magnetic resonance imaging/magnetic resonance spectroscopy. Journal of Magnetic Resonance Imaging 17, 136-41
28. Walker RC, Purnell GL, Jones-Jackson LB, Thomas KL, Brito JA, Ferris EJ (2004) Introduction to PET imaging with emphasis on biomedical research. Neurotoxicology 25, 533-42
29. Wang YX (2005) Medical imaging in pharmaceutical clinical trials: what radiologists should know. Clinical Radiology 60, 1051-7
30. Wang YX, Betton G, Floettmann E, Liess C (2006) MRI histopathology correlation of N-phenylanthranilic acid induced nephropathy in rats. British Journal of Radiology 79, 1009-10
31. Wang YX, Betton G, Floettmann E, Fantham E, Ridgwell G (2007) Imaging kidney in conscious rats with high-frequency ultrasound and detection of two cases of unilateral congenital hydronephrosis. Ultrasound in Medicine and Biology 33, 483-6
32. Wang YX, Emery CJ, Laude E, Morcos SK (1997) Effects of radiographic contrast media on the tensions of isolated small pulmonary arteries. British Journal of Radiology 70, 1229-38
33. Wang YX, Jia YF, Chen KM, Morcos SK (2001) Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. British Journal of Radiology 74, 1103-8
34. Wassmuth R, Lentzsch S, Erdbruegger U, et al. (2001) Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - a pilot study. American Heart Journal 141, 1007-13
35. Williams RE, Prior M, Bachelard HS, Waterton JC, Checkley D, Lock EA (2001) MRI studies of the neurotoxic effects of L-2-chloropropionic acid on rat brain. Magnetic Resonance Imaging 19, 133-42
36. Yarrington JT, Gibson JP, Dillberger JE, et al. (1993) Sequential neuropathology of dogs treated with vigabatrin, a GABA-transaminase inhibitor. Toxicologic Pathology 21, 480-9
37. Zhang X, Tengowski M, Fasulo L, Botts S, Suddarth SA, Johnson GA (2004) Measurement of fat/water ratios in rat liver using 3D three-point dixon MRI. Magnetic Resonance in Medicine 51, 697-702
38. Zhou X, Maronpot RR, Hedlund LW, Cofer GP, Johnson GA (1995) Detection of bromobenzene-induced hepatocellular necrosis using magnetic resonance microscopy. Magnetic Resonance in Medicine 34, 853-7